Elucidating the role of 17β hydroxysteroid dehydrogenase type 14 in normal physiology and in breast cancer
Oestrogens play key roles in the development of the majority of breast tumours, a fact that has been exploited successfully in treating breast cancer with tamoxifen, which is a selective oestrogen receptor modulator. In post-menopausal women, oestrogens are synthesised in peripheral hormone-target t...
Main Author: | Sivik, Tove |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Linköpings universitet, Onkologi
2012
|
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-84686 http://nbn-resolving.de/urn:isbn:978-91-7519-763-0 |
Similar Items
-
17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.
by: Tove Sivik, et al.
Published: (2012-01-01) -
Role of 17β-hydroxysteroid dehydrogenase type 5 in breast cancer studied by intracrinology
by: Xu, Dan (Ph.D)
Published: (2015) -
17β-hydroxysteroid dehydrogenase types 1 and 2 in human normal and malignant breast and gastrointestinal tract
by: Oduwole, O. (Olayiwola)
Published: (2003) -
The role of the androgen receptor and hydroxysteroid 17β dehydrogenase in breast cancer : Impact on tamoxifen treatment
by: Hilborn, Erik
Published: (2016) -
Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1).
by: Alessandro Spadaro, et al.
Published: (2012-01-01)